Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2020-06-22 2020-06-22
Drug Identification Number 02388316 02388316
Brand name XIAFLEX XIAFLEX
Common or Proper name COLLAGENASE CLOSTRIDIUM HISTOLYTICUM COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
Company Name ENDO VENTURES LTD. ENDO VENTURES LTD.
Ingredients COLLAGENASE CLOSTRIDIUM HISTOLYTICUM COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
Strength(s) 0.9MG 0.9MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRALESIONAL INTRALESIONAL INTRALESIONAL INTRALESIONAL
Packaging size 1 Vial 1 Vial
ATC code M09AB M09AB
ATC description OTHER DRUGS FOR DISORD. OF THE MUSCULO-SKELET.SYST OTHER DRUGS FOR DISORD. OF THE MUSCULO-SKELET.SYST
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-06-15 2020-06-15
Actual discontinuation date 2020-06-15 2020-06-15
Remaining supply date 2020-06-15 2020-06-15
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments